The MicroIBioM study: the gut microbiome in inclusion body myositis

General differences of gut microbiome seem unlikely to play a role in the genesis of IBM. Whether the late occurring or the more specific differences detected are part of the disease course needs to be addressed by investigations of further biosamples.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Rheumatology
Published
2025-06-12
DOI
https://doi.org/10.55563/clinexprheumatol/1b8sv1
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The MicroIBioM study: the gut microbiome in inclusion body myositis

W. Seel, Cornelia Kornblum, Marie-Christine Simon, Jens Reimann et al.
Clinical and Experimental Rheumatology
Inflammatory Myopathies and Dermatomyositis
article

The MicroIBioM study: the gut microbiome in inclusion body myositis

W. Seel, Cornelia Kornblum, Marie-Christine Simon, Jens Reimann, Maren Winkler
article en

Abstract

General differences of gut microbiome seem unlikely to play a role in the genesis of IBM. Whether the late occurring or the more specific differences detected are part of the disease course needs to be addressed by investigations of further biosamples.

Clinical and Experimental RheumatologyVol. 44(2)
University of Bonn (DE), University Hospital Bonn (DE), Jena University Hospital (DE)
Openalex Percentile: Top 27%
Inflammatory Myopathies and Dermatomyositis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.